Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 7807.016 | 0.9697 | 0.9716 | 2.1516 | ||
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 7808.016 | 0.8898 | 0.8985 | 2.2401 | ||
HBL-100 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 100 | uM | 7808.05 | 0.0398 | -0.4445 | 2.5177 | |
HMT-3522 S1 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.000256 | uM | 7911.05 | 1.0153 | 1.0170 | 1.7938 | |
HMT-3522 S1 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.16 | uM | 7911.05 | 0.3851 | 0.1749 | 1.7938 | |
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.000427 | uM | 7807.016 | 0.9671 | 0.9691 | 2.1516 | ||
HMT-3522 S1 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 4 | uM | 7911.05 | 0.3947 | 0.1911 | 1.7938 | |
HMT-3522 S1 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 20 | uM | 7911.05 | 0.3560 | 0.1245 | 1.7938 | |
MB 157 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.00128 | uM | 9039.05 | 1.0404 | 1.1936 | 0.4285 | |
MB 157 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.0064 | uM | 9039.05 | 0.9736 | 0.8791 | 0.4285 | |
MB 157 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.16 | uM | 9039.05 | 0.8235 | 0.2713 | 0.4285 | |
MB 157 | Unknown | Unknown | 17-AAG | HSP90 | HSP90 | 0.8 | uM | 9039.05 | 0.4024 | -0.7611 | 0.4285 | |
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 7807.016 | 0.9478 | 0.9508 | 2.1516 | ||
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 7808.016 | 1.1398 | 1.1203 | 2.2401 | ||
HMT-3522 S1 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.00213 | uM | 7911.016 | 0.9651 | 0.9473 | 1.3310 | ||
HMT-3522 S1 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0107 | uM | 7911.016 | 1.0750 | 1.1117 | 1.3310 | ||
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 6.67 | uM | 7807.016 | 0.8955 | 0.9000 | 2.1516 | ||
HMT-3522 S1 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 7911.016 | 0.7317 | 0.5816 | 1.3310 | ||
HMT-3522 S1 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 33.3 | uM | 7911.016 | 0.0303 | -0.8555 | 1.3310 | ||
HMT-3522 S1 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 167 | uM | 7911.016 | 0.0820 | -0.6946 | 1.3310 | ||
HBL-100 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 7807.016 | 0.9831 | 0.9842 | 2.1516 | ||
MB 157 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 0.0533 | uM | 9039.016 | 0.9542 | 0.8358 | 0.5468 | ||
MB 157 | Unknown | Unknown | (Z)-4-Hydroxytamoxifen | ESR1 | 1.33 | uM | 9039.016 | 0.8943 | 0.6305 | 0.5468 | ||
MX1 | Unknown | Unknown | 2-deoxyglucose | 0.213 | uM | 12667.177 | 1.0184 | 1.0629 | 0.5892 | |||
MX1 | Unknown | Unknown | 2-deoxyglucose | 0.0427 | uM | 12667.177 | 0.8943 | 0.6545 | 0.5892 |